PER 0.00% 10.0¢ percheron therapeutics limited

An FDA Act that may be relvant to ATL-1102 FDA, page-144

  1. 2,623 Posts.
    lightbulb Created with Sketch. 1370
    Hope you're right RYNZN - I've been in and out of ANP for some years but recently I see it as being very much de-risked and I have changed my way of thinking to a L/Term view and consequently I've had a real good crack at ANP and have committed cash quite heavily of late and am thinking like you also that a major re-rate is becoming more likely then ever.

    If the BOD's at Sarepta have any nous they will be plotting on an offer for our company but that's another story.

    Good luck to all you ANP investor folk
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.